arrow
M

Mónica V. Estrada

University of California San Diego
H指数:31
被引数:9,084

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term exposure to house dust mites accelerates lung cancer development in mice
2023-01-216
OAAI
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer
2019-09-2333
OAAI
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer (vol 77, pg 2488, 2017)
2019-02-151
PREAI
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
2018-12-20156
OA
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

评估实体瘤中的肿瘤浸润淋巴细胞: 国际免疫肿瘤学生物标志物工作组对病理学家的实践回顾和标准化方法的建议: 第2部分: 黑色素瘤,胃肠道癌,非小细胞肺癌和间皮瘤中的til,子宫内膜癌和卵巢癌,头颈部鳞状细胞癌,泌尿生殖系统癌和原发性脑肿瘤

2017-11-01486
OAAI
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

评估实体瘤中的肿瘤浸润淋巴细胞: 国际免疫肿瘤学生物标志物工作组对病理学家的实践回顾和标准化方法的建议: 第1部分: 评估宿主免疫反应,浸润性乳腺癌和原位导管癌中的til,转移性肿瘤沉积和进一步研究的领域

2017-09-01610
OAAI
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
2017-08-0990
OAAI
HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2
2017-08-0166
OAAI
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

细胞外基质/整合素信号促进HER2乳腺癌对HER2和PI3K联合抑制的抵抗

2017-06-1487
OAAI
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+Breast Cancers With ERBB Ligand Overexpression
2017-06-0331
OAAI
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
2017-05-2483
OAAI